Pfizer to acquire King Pharmaceuticals for $3.6 billion in cash
October 12th, 2010 - 8:26 pm ICT by BNO NewsNEW YORK (BNO NEWS) — Pfizer and King Pharmaceuticals on Tuesday announced that they have entered into a definitive merger agreement in which Pfizer will acquire King for $3.6 billion in cash, or $14.25 per share.
The transaction represents a premium of approximately 40 percent to King’s closing price as of October 11, 2010 and 46 percent percent to the one-month average closing price as of the same date. The companies said the transaction was approved by the boards of both companies.
The merger agreement will further expand Pfizer’s business profile, providing a prescription pharmaceutical business focused on delivering new formulations of pain treatments, the Meridian auto injector business for emergency drug delivery, and an animal health business that offers a variety of feed additive products for a wide range of species.
“This strategic combination will allow Pfizer to leverage its existing commercial capabilities and expertise to create one of the leading broad portfolios for pain relief and management in the biopharmaceutical industry,” the companies said.
Pfizer anticipates the transaction to yield initial cost savings from operating expenses of at least $200 million, which are expected to be fully realized by the end of 2013.
The transaction is not expected to impact Pfizer’s 2010 financial guidance, the company said, adding the company continues to expect to achieve its 2012 financial targets.
- Capitol One to acquire HSBC's domestic credit card business for $2.6 billion - Aug 10, 2011
- Novell agrees to be acquired by Attachmate Corporation for $2.2 billion - Nov 22, 2010
- Kanoria Chemicals to acquire Switzerland-based firm - Apr 20, 2012
- Biocon ties up with Pfizer to market biosimilars - Oct 18, 2010
- Bharti to exit from financial services joint venture with AXA - Jun 10, 2011
- Jo-Ann Stores to be acquired by Leonard Green for $1.6 billion - Dec 24, 2010
- Orchid Chemicals declares 30 percent dividend - May 18, 2011
- Pfizer to Buy King Pharmaceuticals for $3.6 Billion - Oct 13, 2010
- Dr.Reddy's acquires JB Chemicals business in Russia - Jul 23, 2011
- Curb deceptive marketing gigs: Court - Jun 20, 2011
- RIL calls off acquisition of Bharti AXA - Nov 25, 2011
- Dr Reddy's acquires US-based oral penicillin facility - Nov 24, 2010
- Non-life insurers post 19 percent growth in April - May 31, 2011
- Google to buy Motorola Mobility for $12.5 bn - Aug 16, 2011
- Biocon quarterly net profit up 25 percent - Apr 28, 2011
Tags: animal health business, biopharmaceutical industry, bno, business profile, commercial capabilities, definitive merger agreement, drug delivery, emergency drug, feed additive, financial guidance, financial targets, king pharmaceuticals, meridian, october 11, operating expenses, pain relief, pfizer, pharmaceutical business, portfolios